Healthcare · NASDAQ
Regeneron Pharmaceuticals, Inc. earns a composite grade of B (Strong). Crash risk is rated A (Low).
Composite
B
Strong
Earnings
C
Declining
Crash risk
A
Low
Profitability
B+
Growth
D
Financial Health
A+
Cash Flow Quality
A+
Valuation
C+
Earnings Consistency
C
Analyst Sentiment
N/A
Not rated